Phase II and III Cardiovascular Adjudication Program for Evaluation of Efficacy and Safety of VDPHL01
Clinical Trial Grant
Awarded By
VeraDermics Inc.
Start Date
February 5, 2025
End Date
February 28, 2027
Awarded By
VeraDermics Inc.
Start Date
February 5, 2025
End Date
February 28, 2027